Managment and prognosis of portal vein cavernosis in 65 adults
10.3760/cma.j.cn113855-20220121-00045
- VernacularTitle:成人门静脉海绵样变治疗效果分析
- Author:
Lin LI
1
;
Xiaowei DANG
;
Luhao LI
;
Suxin LI
;
Peiju WANG
;
Dongqi SHEN
;
Shengyan LIU
Author Information
1. 郑州大学第一附属医院肝胆外科，郑州 450052
- Keywords:
Hypertension,portal;
Portasystennic shunt,tanjugular intrahepatic;
Splenectomy
- From:
Chinese Journal of General Surgery
2022;37(6):410-413
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical treatment options for cavernous transformation of portal vein (CTPV).Methods:Data of 65 CTPV patients receiving invasive treatment and followed up at the First Affiliated Hospital of Zhengzhou University between Apr 2011 and Apr 2021 were collected. Patients were divided into four groups based on different treatment option, 24 patients were treated with transjugular intrahepatic portosystemic stent-shunt (TIPS) and 11 patients with splenopneumopexy, while 22 patients underwent splenectomy and devascularization , 8 were treated by endoscopic variceal ligation . The difference of postoperative upper gastrointestinal bleeding and hepatic encephalopathy between the four groups were analyzed,Results:There were no difference between four groups in sex, age, preoperative serum aspartate aminotransferase, total bilirubin, albuminand Child-Turcotte-Pugh grade. The incidence of hepatic encephalopathy in the TIPS group was 33.3%±9.6%、46.5%±10.3% and 64.4%±13.1% in half year, 1 year, and 3 years , respectively. Postoperative hepatic encephalopathy rate was higher in TIPS group( χ2=31.191, P=0.000). Three patients in the TIPS group developed upper gastrointestinal hemorrhage within 6 months after the operation, and postoperative upper gastrointestinal bleeding rate was higher in splenopneumopexy group( χ2=7.542, P=0.006), Conclusion:The clinical treatment options for CTPV patients are complicated ,we should make individual treatment options depend on the etiology, clinical symptoms and site of blood flow obstruction.
